Pacer Advisors, Inc. has filed its 13F form on May 06, 2025 for Q1 2025 where it was disclosed a total value porftolio of $35.5 Billion distributed in 3649 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Exxon Mobil Corp with a value of $598M, Chevron Corp with a value of $577M, Conocophillips with a value of $567M, Altria Group, Inc. with a value of $565M, and At&T Inc. with a value of $565M.
Examining the 13F form we can see an decrease of $5.03B in the current position value, from $40.5B to 35.5B .
Pacer Advisors, Inc. is based out at Malvern, PA
Below you can find more details about Pacer Advisors, Inc. portfolio as well as his latest detailed transactions.
Portfolio value
$35.5 Billion
Technology: $7.24 Billion
Energy: $5.86 Billion
Healthcare: $5.44 Billion
Consumer Cyclical: $4.91 Billion
Industrials: $3.68 Billion
Communication Services: $2.84 Billion
Consumer Defensive: $2.56 Billion
Basic Materials: $1.14 Billion
Other: $1.83 Billion
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 56.22%
Energean Israel Finance LTD
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.6%
Energean Israel Finance LTD
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
Garda World Security Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.47%
Garda World Security Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.33%
Garda World Security Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
Garda World Security Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
Garda World Security Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.47%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.6%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 65.38%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.6%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 72.29%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.41%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 60.87%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.57%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 57.39%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.33%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.41%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.02%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.41%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.59%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.33%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 55.15%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 55.42%
-
$0
0.0% of portfolio
-
Q1 2025
New
Rogers Communications Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
Rogers Communications Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
Rogers Communications Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Added 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Added 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Added 52.63%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.6%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.41%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.41%
Teva Pharmaceutical Finance Netherlands Iii Bv
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.33%
Teva Pharmaceutical Finance Netherlands Iii Bv
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 56.31%